Streetbeat News

Equity Actions

SBUX

Nelson Peltz's Trian Fund Management has sold its substantial stake in Starbucks after being satisfied with the recent outcomes. Trian had built this stake over the past few months.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 4:10 pm

MSTR

Recent unusual options activity for MicroStrategy (NASDAQ:MSTR) indicates a bullish sentiment among deep-pocketed investors. Benzinga's options scanner highlighted 46 significant options trades, with a notable volume and open interest. Analysts maintain a Buy rating with high target prices.

Portfolio Pulse from Benzinga Insights

August 13, 2024 | 4:01 pm

MRNA

Financial giants have made significant bearish moves on Moderna (NASDAQ:MRNA) through options trading. Analysis shows 76% of trades are bearish, with major market movers focusing on a price range of $65.0 to $200.0. Moderna's stock is currently trading at $81.77, with mixed analyst ratings and an upcoming earnings report in 79 days.

Portfolio Pulse from Benzinga Insights

August 13, 2024 | 4:01 pm

ASTI

Ascent Solar Technologies shares are trading lower after the company announced a 1-for-100 reverse stock split, effective August 15, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 3:48 pm

ASTI

Ascent Solar Technologies (NASDAQ:ASTI) announced a 1-for-100 reverse stock split effective August 15, 2024. This move aims to consolidate shares and potentially increase the stock price.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 3:46 pm

GNS

Genius Group Limited (NYSE:GNS) has announced that its Board has approved the dual listing of its shares on the Frankfurt Stock Exchange. The company expects trading to begin within the next month, pending approval from the Frankfurt Stock Exchange.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 3:36 pm

AMSC

On August 12, 2024, American Superconductor filed a prospectus for the resale of up to 1.3 million shares of common stock with the SEC.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 3:24 pm

ACTU

Actuate Therapeutics shares opened for trade at $9.88 per share after pricing its IPO at $8 per share on 2.8 million shares.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 2:54 pm

CEP

Cantor Equity Partners (CEP) shares opened for trade at $10.01 per share following an IPO priced at $10 per share on 10 million shares.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 2:53 pm

CEP

Cantor Equity Partners, Inc. (NASDAQ:CEP) has priced its initial public offering (IPO) of 10 million Class A shares at $10 per share. The shares will be listed on the Nasdaq Global Market and will begin trading under the symbol 'CEP' on August 13, 2024. The underwriters have a 45-day option to purchase an additional 1.5 million shares to cover over-allotments. The offering is expected to close on August 14, 2024, with Cantor Fitzgerald & Co. acting as the sole book running manager.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 2:36 pm